Skip to main content
Premium Trial:

Request an Annual Quote

Signature Genomic Licenses Affy Patents for Comparative Genomics Studies

NEW YORK, Feb. 14 (GenomeWeb News) - Signature Genomic Laboratories has licensed an undisclosed number of Affymetrix patents related to the use of microarrays for comparative genomic hybridization studies, Signature said today.

 

The license will be applied to Signature Genomic's SignatureChip microarray-based diagnostics for cytogenic abnormalities, the company said.

 

Additional details of the licensing agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.